Towards optimization of cardiovascular stability in neonates with hypertrophic cardiomyopathy: uniqueness of the neonatal cardiovascular system
- PMID: 33510414
- DOI: 10.1038/s41372-021-00926-w
Towards optimization of cardiovascular stability in neonates with hypertrophic cardiomyopathy: uniqueness of the neonatal cardiovascular system
Comment on
-
Use of vasopressin in neonatal hypertrophic obstructive cardiomyopathy: case series.J Perinatol. 2021 Jan;41(1):126-133. doi: 10.1038/s41372-020-00824-7. Epub 2020 Sep 19. J Perinatol. 2021. PMID: 32951013
-
Vasopressin in neonatal hypertrophic cardiomyopathy: do perceived benefits translate to clinical outcome?J Perinatol. 2021 Apr;41(4):905-906. doi: 10.1038/s41372-021-00937-7. Epub 2021 Feb 18. J Perinatol. 2021. PMID: 33603108 No abstract available.
Similar articles
-
Hypertrophic cardiomyopathy in preterm infants treated with dexamethasone.Eur J Pediatr. 1997 May;156(5):394-6. doi: 10.1007/s004310050623. Eur J Pediatr. 1997. PMID: 9177985
-
The rare association of tetralogy of Fallot with hypertrophic cardiomyopathy. Report of 2 neonatal patients.Tex Heart Inst J. 1997;24(3):215-7. Tex Heart Inst J. 1997. PMID: 9339511 Free PMC article.
-
Cushing's syndrome in pregnancy and neonatal hypertrophic obstructive cardiomyopathy.Acta Paediatr. 2004 Oct;93(10):1400-2. doi: 10.1080/08035250410026626. Acta Paediatr. 2004. PMID: 15499965
-
[Utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathy: when is it superior to echocardiography?].Ann Cardiol Angeiol (Paris). 2015 Feb;64(1):9-13. doi: 10.1016/j.ancard.2014.04.015. Epub 2014 Apr 26. Ann Cardiol Angeiol (Paris). 2015. PMID: 24834991 Review. French.
-
Neonatal cardiac hypertrophy: the role of hyperinsulinism-a review of literature.Eur J Pediatr. 2020 Jan;179(1):39-50. doi: 10.1007/s00431-019-03521-6. Epub 2019 Dec 16. Eur J Pediatr. 2020. PMID: 31840185 Free PMC article. Review.
Cited by
-
New insights in pediatrics in 2021: choices in allergy and immunology, critical care, endocrinology, gastroenterology, genetics, haematology, infectious diseases, neonatology, neurology, nutrition, palliative care, respiratory tract illnesses and telemedicine.Ital J Pediatr. 2022 Nov 26;48(1):189. doi: 10.1186/s13052-022-01374-8. Ital J Pediatr. 2022. PMID: 36435791 Free PMC article. Review.
References
-
- Loomba R, Flores S, Bronicki RA. Vasopressin in neonatal hypertrophic cardiomyopathy: cosmetic or helpful? J Perinatol. 2020.
-
- Deorari AK, Saxena A, Singh M, Shrivastava S. Echocardiographic assessment of infants born to diabetic mothers. Arch Dis Child. 1989;64:721–4. - DOI
-
- Barbara DW, Hyder JA, Behrend TL, Abel MD, Schaff HV, Mauermann WJ. Safety of noncardiac surgery in patients with hypertrophic obstructive cardiomyopathy at a tertiary care center. J Cardiothorac Vasc Anesth. 2016;30:659–64. - DOI
-
- Way GL, Wolfe RR, Eshaghpour E, Bender RL, Jaffe RB, Ruttenberg HD. The natural history of hypertrophic cardiomyopathy in infants of diabetic mothers. J Pediatr. 1979;95:1020–5. - DOI
-
- Gobel FL, Norstrom LA, Nelson RR, Jorgensen CR, Wang Y. The rate-pressure product as an index of myocardial oxygen consumption during exercise in patients with angina pectoris. Circulation. 1978;57:549–56. - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources